Antiviral Medication Adherence Visit 30 October 1, 1998 - March 31, 1999 Visit 31-35 April 1, 1999 - September 30, 2001 Visit 361 October 1, 2001 - March 31, 2002 w/variables Guidelines Visit 371 April 1, 2002 - September 30, 2002 w/variables Guidelines Visit 381 October 1, 2002 - March 31, 2003 w/variables Spanish Guidelines Visit 391 April 1, 2003 - September 30, 2003 w/variables Spanish Guidelines Visit 401 October 1, 2003 - March 31, 2004 w/variables Spanish Guidelines Visit 411 April 1, 2004 - September 30, 2004 w/variables Spanish Guidelines Visit 421 October 1, 2004 - March 31, 2005 w/variables Spanish Guidelines Visit 431 April 1, 2005 - September 30, 2005 w/variables Spanish Guidelines Visit 441 October 1, 2005 - March 31, 2006 w/variables Spanish Guidelines Visit 451 April 1, 2006 - September 30, 2006 w/variables Spanish Guidelines Visit 461 October 1, 2006 - March 31, 2007 w/variables Spanish Guidelines Visit 471 April 1, 2007 - September 30, 2007 w/variables Spanish Guidelines Visit 481 October 1, 2007 - March 31, 2008 w/variables Spanish Guidelines Visit 491 April 1, 2008 - September 30, 2008 w/variables Spanish Guidelines 1 There were no changes from visit 36 through visit 49 Anitviral Medication Adherence form.   At Visit 38 a Spanish version was added. There may be updates to the visit guidelines. You must have Acrobat Reader installed on your computer to view these forms. If you do not have Acrobat Reader installed you can download it for free now. This project has been funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute:U01-AI-35042, 5-M01-RR-00052 (GCRC), U01-AI-35043, U01-AI-37984, U01-AI-35039, U01-AI-35040, U01-AI-37613, U01-AI-35041.            This page was last updated July 2008.